Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Finasteride may cause kidney damage.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Finasteride treats baldness but may cause lasting sexual side effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Finasteride is effective in growing hair and stopping hair loss in men with mild to moderate alopecia.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Testosterone helps human pancreatic cells increase insulin release.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Finasteride effectively treats male hair loss, improving growth and density.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.